This content is machine translated Cutaneous T-cell lymphoma (CTCL) First targeted antibody approved for CTCL patients with MF or SS The approval of the anti-CCR4 antibody mogamulizumab provides patients with cutaneous T-cell lymphoma (CTCL) of the mycosis fungoides (MF) and Sézary syndrome (SS) subtypes with an effective non-chemotherapeutic intervention for…
View Post 8 min This content is machine translated Neoplastic diseases Treatment and prognosis of cutaneous lymphoma Cutaneous lymphomas are a heterogeneous group of neoplastic diseases arising from clonal proliferation of lymphocytes in the skin. Overall, cutaneous lymphomas are rare skin cancers, with a prevalence of 1:100,000…
